# Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

> **NCT00004933** · PHASE3 · TERMINATED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 5 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** hydroxyurea
- **DRUG:** Homoharringtonine

## Key facts

- **NCT ID:** NCT00004933
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-01
- **Primary completion:** 2001-05
- **Final completion:** 2001-05
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2016-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004933, "Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*